Retrieve available abstracts of 6 articles: HTML format
Single Articles
July 2025
WU R, Li X, Wu Y, Zhao Z, et al External validation of population pharmacokinetic models of oxcarbazepine active
metabolite in Chinese children with epilepsy.
Eur J Clin Pharmacol. 2025 Jul 24. doi: 10.1007/s00228-025-03875. PubMedAbstract available
CHEN J, Wang J, Li K, Wu Y, et al Dosing prediction of valproic acid in pediatric patients with epilepsy:
population pharmacokinetic model or machine learning model?
Eur J Clin Pharmacol. 2025 Jul 5. doi: 10.1007/s00228-025-03874. PubMedAbstract available
February 2025
WANG S, Sun H, Wang Z, Sun C, et al Adjunctive treatment for pediatric focal epilepsy: a systematic review.
Eur J Clin Pharmacol. 2025 Feb 13. doi: 10.1007/s00228-025-03807. PubMedAbstract available
November 2024
PRETORIUS E, van Zyl P, Joubert G Therapeutic drug monitoring for valproate: deriving a novel formula for
calculation of free concentration.
Eur J Clin Pharmacol. 2024;80:1751-1759. PubMedAbstract available
August 2024
WU R, Li K, Zhao Z, Mei S, et al Fixed parameters in the population pharmacokinetic modeling of valproic acid
might not be suitable: external validation in Chinese adults with epilepsy or
after neurosurgery.
Eur J Clin Pharmacol. 2024 Aug 29. doi: 10.1007/s00228-024-03746. PubMedAbstract available
October 2023
CHEN J, Huang L, Zeng L, Jiang Z, et al The reference range of lamotrigine in the treatment of epilepsy in children: a
systematic review.
Eur J Clin Pharmacol. 2023 Oct 31. doi: 10.1007/s00228-023-03562. PubMedAbstract available